Antibody Therapy vs Vaccine: With AstraZeneca's... - CLL Support

CLL Support

23,325 members40,029 posts

Antibody Therapy vs Vaccine

gardening-girl profile image
9 Replies

With AstraZeneca's announcement today of positive high-level results from an interim analysis of clinical trials of their vaccine candidate AZD1222, I felt compelled to post the picture above that highlights the differences between vaccines and antibody therapy. Antibody therapy is not a vaccine and should not be referred to as such.

AstraZeneca now has late-stage candidates in both categories. AZD1222 is an adenovirus vector vaccine candidate (astrazeneca.com/media-centr... and AZD7442 is a monoclonal therapy (astrazeneca.com/media-centr.... This may lead to confusion when discussing them on this forum so it will be important to specify which AstraZeneca product is being discussed.

I've added just a few of the antibody therapy and vaccine candidates to the figure. There are plenty more in the pipeline around the world!

The figure is from vumc.org/viiii/spotlight/an...

gardening-girl

P.S. Although not shown in this diagram, the antibody therapy may eventually be approved for prophylactic use.

Written by
gardening-girl profile image
gardening-girl
To view profiles and participate in discussions please or .
Read more about...
9 Replies
lankisterguy profile image
lankisterguyVolunteer

Fantastic explanation and graphics. Thanks for finding and sharing that info gardening-girl Len

Justasheet1 profile image
Justasheet1

Wow, really great and simple explanation. I agree with Len. Thanks GG.

bennevisplace profile image
bennevisplace

Thanks for this g-g, and here is a good source on Covid19 drug and vaccine candidates genengnews.com/covid-19-can...

Informative, if not always up to date.

It's a big field.

FRONT RUNNERS include the Gamalea, Pfizer, Moderna and Oxford/ AZ vaccines.

DEFINITELY MAYBE includes the AZD7442 antibody, phase 3 trial now recruiting, as well as some erstwhile candidates that already bombed.

If you click on a drug/ vaccine of interest and scroll down, you can select candidates categorised by VAX, RNA (incl vaxes), ANTIBODY and ANTIVIRAL.

gardening-girl profile image
gardening-girl in reply tobennevisplace

bennevisplace, I'm excited and dizzy from trying to navigate the GEN site!😩 An almost overwhelming amount of info there! I've bookmarked the site and will be checking it frequently. Thanks very much for the link!

bennevisplace profile image
bennevisplace in reply togardening-girl

Glad to add to your stack of reading! I always appreciate your very well informed input.

cllady01 profile image
cllady01Former Volunteer

G-G (thanks for that appropriate shortening, bennevisplace . Also THANK YOU both for this most informative and fantastic thread contents.

Fran57 profile image
Fran57

Thanks so much for that information and explanations.Stay safe,

Fran 😉

wmay13241 profile image
wmay13241

For immuno-compromised people who receive repeated IVIG due to low immunoglobulins, l think the mRNA vaccines offer the best chance to be effective for a long period of time.

Hoffy profile image
Hoffy

Thanks!!

Not what you're looking for?

You may also like...

UK first to trial AstraZeneca 'antibody cocktail' aimed at non-vaccine patients

I'm not recruiting for Astrazeneca, but news broke this morning that they are to start phase 3...

acalabrutinib gets Breakthrough Therapy Designation for CLL from FDA

https://www.astrazeneca.com/media-centre/press-releases/2019/calquence-granted-us-breakthrough-thera
avzuclav profile image

Calling UK CLLers - Is government about to abandon support for protective monoclonal antibodies?

There is ample evidence now that many CLL patients don't respond well to vaccination against the...

Acalabrutinib exhibits comparable efficacy, superior safety to ibrutinib for CLL (finally!)

Positive high-level results from the ELEVATE-RR Phase III trial showed AstraZeneca’s Calquence...
avzuclav profile image

..however, after a second dose there is only a small and non-significant reduction in vaccine effectiveness

In most clinical risk groups, immune response to vaccination is maintained and high levels of VE...
zaax profile image